Frontline Ltd. (NYSE:FRO) ("Frontline" or the "Company") today announced that it has entered into a private agreement to exchange $25 million of the outstanding principal amount of the Company's 4.5% Convertible Bond Issue 2010/2015 (the "Bonds") for an aggregate of approximately 5.8 million shares at an exchange price of $2.41 per share, the closing price of the Company's shares on the New York Stock Exchange on October 10, 2013, and a cash payment of $2,250,000. In addition, under the exchange agreement, Frontline has agreed to issue, on October 18, 2013, up to an additional 1.2 million shares to the holders of the Bonds based on an agreed formula if the 5-day volume-weighted average price (VWAP) of the Company's shares, for the period ending October 17, 2013, is lower than the exchange price, subject to a minimum VWAP price of $2.00 per share.
The issuance of the common shares to the holders of the Bonds is expected to close on October 16, 2013.
October 11, 2013 The Board of Directors Frontline Ltd. Hamilton, Bermuda
Questions should be directed to: Jens Martin Jensen: Chief Executive Officer, Frontline Management AS +47 23 11 40 00 Inger M. Klemp: Chief Financial Officer, Frontline Management AS +47 23 11 40 00
FORWARD LOOKING STATEMENTS
This report contains forward-looking statements including but not limited to statements regarding the Company's financing activities and other future activities. These forward-looking statements are subject to risks and uncertainties, and actual results may differ materially. Certain factors that may affect actual results to differ materially include, without limitation, our ability to complete and a delay in completing the debt-for-equity exchange described above. Please refer to Frontline's SEC filings for more information on the other factors that could cause actual results to differ materially from expectations, specifically the sections titled "Risk Factors" and "Forward-Looking Statements" in the Company's Annual Report on Form 20-F.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.